Fasting insulin and HbA1c both measure glucose metabolism, but they detect dysfunction at different stages — and the gap between them can be 5-10 years. If you want to know whether your metabolism is heading toward insulin resistance before it becomes prediabetes, fasting insulin is the marker that moves first. This guide covers what each marker measures, when each becomes abnormal, and why checking both is the only way to see the full metabolic timeline.
- Fasting insulin rises 5-10 years before HbA1c crosses into prediabetes range, making it the earliest marker of dysfunction.
- HbA1c is a 3-month average of glucose exposure; it stays normal while the pancreas compensates by overproducing insulin.
- HOMA-IR — (fasting glucose x fasting insulin) / 405 — quantifies insulin resistance even when glucose and HbA1c look normal.
- The triglyceride-to-HDL ratio is a free proxy for insulin resistance when fasting insulin isn't ordered.
- Elevated fasting insulin with normal HbA1c is fully reversible with lifestyle changes; waiting until HbA1c moves narrows that window.
TL;DR
Fasting insulin rises 5-10 years before HbA1c crosses into prediabetes range. HbA1c is a 3-month average of glucose exposure; fasting insulin is a real-time measure of how hard your pancreas is working to keep glucose normal. How doctors diagnose insulin resistance starts with fasting insulin and HOMA-IR, not HbA1c. Verdict: in 2026, an annual physical that checks HbA1c but not fasting insulin is screening for diabetes 5-10 years too late.
Fasting insulin rises 5-10 years before HbA1c crosses into prediabetes range.
Why this matters
The standard metabolic screening in primary care is fasting glucose and HbA1c. Both stay normal during the early stages of insulin resistance because the pancreas compensates by producing more insulin. The extra insulin keeps glucose in range — but it does so at the cost of promoting fat storage, particularly visceral fat, and accelerating the progression toward type 2 diabetes.
Fasting insulin captures this compensatory phase. A fasting insulin of 15 uIU/mL with a fasting glucose of 92 mg/dL and an HbA1c of 5.3% looks completely normal on a standard panel. But the HOMA-IR is 3.4 — well into insulin resistance. Without the fasting insulin value, this patient would be told their labs are fine for another 5 years.
What you'll need
- A fasting insulin blood test (requires 8-12 hours fasting, water only)
- A fasting glucose test drawn at the same visit
- An HbA1c result (does not require fasting)
- A lipid panel including triglycerides and HDL
- A calculator for HOMA-IR: (fasting glucose x fasting insulin) / 405
- A clinician who interprets all three markers together
The steps
1. Understand what HbA1c actually measures
HbA1c reflects the percentage of hemoglobin proteins coated with glucose (glycated) over the past 3 months. It is a lagging average — it tells you what happened, not what is happening. An HbA1c of 5.4% means your average glucose over the past 90 days was approximately 108 mg/dL. How doctors use HbA1c to guide treatment covers the clinical interpretation in detail. HbA1c is excellent for tracking progression and diagnosis but poor for early detection because it only rises after glucose has been elevated for months. Common mistake: treating a normal HbA1c as proof that glucose metabolism is healthy — it only means your average glucose was normal over 3 months, not that insulin sensitivity is intact.
2. Understand what fasting insulin measures
Fasting insulin is the concentration of insulin in your blood after 8-12 hours without food. It reflects how much insulin your pancreas is producing to maintain fasting glucose. When insulin resistance develops, cells become less responsive to insulin, so the pancreas produces more to compensate. Fasting insulin rises before fasting glucose — the pancreas keeps glucose normal by overproducing insulin. This is why fasting insulin is the earliest biochemical marker of insulin resistance. Common mistake: not knowing that fasting insulin is not part of a standard annual physical — you have to ask for it by name.
3. Calculate HOMA-IR to see the relationship
HOMA-IR uses both values: (fasting glucose in mg/dL x fasting insulin in uIU/mL) / 405. The result quantifies insulin resistance as a single number. Below 1.0 is excellent sensitivity. Above 2.5 is insulin resistance. Above 4.0 is significant resistance. A patient with glucose of 95 and insulin of 18 has a HOMA-IR of 4.2 — insulin resistance — even though glucose and HbA1c look normal. Insulin resistance and weight gain: what the labs reveal covers the clinical implications. Common mistake: looking at fasting insulin and fasting glucose separately — the diagnostic power is in the relationship, not either number alone.
4. Know the timeline: which marker moves first
The metabolic timeline from insulin resistance to diabetes follows a predictable lab sequence:
Metabolic Timeline
Insulin moves first, glucose second, HbA1c last
| Timeframe | What changes |
|---|---|
| Year 1-5 | Fasting insulin rises (above 10 uIU/mL); glucose and HbA1c stay normal |
| Year 3-7 | Post-meal glucose spikes above 140 mg/dL; fasting glucose may start creeping above 95 |
| Year 5-8 | HbA1c crosses 5.7% (prediabetes); fasting insulin is significantly elevated |
| Year 8-10 | HbA1c crosses 6.5% (diabetes); insulin production may begin to decline |
This timeline varies by individual, but the sequence — insulin first, glucose second, HbA1c last — is consistent. Common mistake: relying on HbA1c as the first-line screen. It is the last marker to move, not the first.
5. Use the triglyceride-to-HDL ratio as a free proxy
If your clinician will not order fasting insulin, the triglyceride-to-HDL ratio is a reliable proxy that costs nothing extra. A ratio above 3.0 suggests insulin resistance; above 4.0 indicates significant resistance. This ratio shifts because insulin resistance increases triglyceride production and lowers HDL. What bloodwork to request at your first weight loss visit includes this ratio in the full panel. Common mistake: ignoring the triglyceride-to-HDL ratio because LDL looks normal — LDL does not reflect insulin sensitivity.
6. Track both markers over time
If you have both fasting insulin and HbA1c, track them together at 6-12 month intervals. A rising fasting insulin with stable HbA1c means insulin resistance is progressing — the compensatory phase is active. A rising HbA1c means the compensation is failing. The combination tells you where you are on the timeline and whether intervention is working.
7. Intervene based on the earliest marker, not the latest
If fasting insulin is elevated but HbA1c is normal, the intervention is lifestyle: reduce refined carbohydrates, add resistance training 2-3x per week, increase fiber to 30g+ daily, and target 5-10% weight loss if overweight. This stage is fully reversible. If HbA1c has entered prediabetes range, metformin or a GLP-1 may be indicated alongside lifestyle changes. What happens at a metabolic health evaluation covers the full clinical assessment. Common mistake: waiting until HbA1c crosses 5.7% to start intervening — by then, insulin resistance has been present for years.
Troubleshooting
Your fasting insulin is 14 uIU/mL but your clinician said it is normal. Standard lab reference ranges for fasting insulin go up to 25 uIU/mL. A result of 14 is flagged normal but is clinically elevated — most clinicians who manage insulin resistance target below 8-10. Ask for the actual number.
A fasting insulin of 14 uIU/mL is flagged normal on a standard lab range that runs up to 25 uIU/mL, but it is clinically elevated — most clinicians managing insulin resistance target below 8-10 uIU/mL. Always ask for the actual number, not just the flag.
Your HbA1c is 5.5% and your clinician said it is fine. An HbA1c of 5.5% is technically normal but is in the upper half of the normal range. If it was 5.1% a year ago, it is trending upward. Check fasting insulin.
Your fasting glucose is 88 mg/dL, which seems great. Fasting glucose below 90 with elevated fasting insulin means the pancreas is working hard to keep it there. This is the compensatory phase — not a sign of metabolic health.
Your triglycerides are 190 mg/dL and HDL is 35 mg/dL. The ratio is 5.4 — significant insulin resistance. Check fasting insulin and HOMA-IR to confirm.
You lost 10 pounds and your HbA1c did not change. HbA1c is a 3-month average and moves slowly. Check fasting insulin instead — it responds to weight loss within 4-8 weeks.
Your clinician will not order fasting insulin. Ask for it by name: "I want a fasting insulin level drawn with my fasting glucose." If they decline, find a clinician who will — this is a standard test, not a specialty.
Tools and resources
- A fasting insulin and fasting glucose lab order (same draw, same visit)
- A HOMA-IR calculator
- A lipid panel including triglycerides and HDL
- A 12-month tracking spreadsheet for fasting insulin, HbA1c, and triglyceride-to-HDL ratio
What to do next
If you have never had fasting insulin checked, request it at your next lab draw. If your clinician does not routinely order it, read about what bloodwork to request at your first weight loss visit and bring the list to your appointment.
FAQ
Is fasting insulin more accurate than HbA1c? They measure different things. Fasting insulin detects insulin resistance earlier — it rises years before HbA1c. HbA1c tracks average glucose over 3 months and is better for monitoring progression once glucose starts rising. Both are needed; neither replaces the other.
What fasting insulin level indicates insulin resistance? Above 8-10 uIU/mL with normal fasting glucose suggests early insulin resistance. Standard lab ranges go higher (up to 25 uIU/mL), so a result flagged normal may still be clinically elevated.
Can HbA1c be normal when insulin resistance is present? Yes — this is the most common pattern in early insulin resistance. The pancreas compensates by producing more insulin, keeping glucose normal. HbA1c stays in range while fasting insulin is elevated.
What is HOMA-IR and what is the cutoff for insulin resistance? HOMA-IR = (fasting glucose x fasting insulin) / 405. Below 1.0 is excellent sensitivity. Above 2.5 indicates insulin resistance. Above 4.0 indicates significant resistance.
How often should fasting insulin be checked? Annually for low-risk patients, every 6 months for patients with risk factors (family history, obesity, metabolic syndrome), and every 12 weeks for patients actively treating insulin resistance.
Does weight loss lower fasting insulin? Yes — even 5-10% weight loss can reduce fasting insulin significantly. Fasting insulin often drops within 4-8 weeks of starting lifestyle changes or GLP-1 therapy.
Why does my doctor only check HbA1c and not fasting insulin? Fasting insulin is not part of standard insurance-based screening panels. It requires the clinician to specifically order it. Many insurance-based practices default to HbA1c because it is the screening test with the clearest insurance billing code.
What is the triglyceride-to-HDL ratio for insulin resistance? A ratio above 3.0 suggests insulin resistance; above 4.0 indicates significant resistance. This ratio is a free proxy if you already have a lipid panel.
One last thing
The 5-10 year gap between when fasting insulin rises and when HbA1c crosses into prediabetes is the window where insulin resistance is fully reversible. Once HbA1c moves, the reversal is harder and slower. A clinician who checks only HbA1c is giving up that entire window in 2026.
Related Reading
- A1C and Weight Loss: What the Labs Show in 2026
- Annual Wellness Visit vs Physical Exam: The 2026 Difference
- Labs Before Hormone Therapy 2026: The Non-Negotiable Panel
- Best GLP-1 for Weight Loss in 2026 | Ranked
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/